Christos Sotiriou, MD, PhD is a medical oncologist specialized in breast cancer and actively involved in the treatment of breast cancer patients. He is head of the Functional Genomics & Translational Research Unit at Jules Bordet Institute, Brussels, Belgium. Dr. Sotiriou’s research focuses on genomics and molecular biology in breast cancer. Dr. Christos Sotiriou earned a medical degree from the Université Libre de Bruxelles, Belgium, in 1993. He did his internal medicine/oncology residency at the Institut Jules Bordet and earned his specialty in this field in July 1999. From October 1999 through September 2001, he worked as basic research fellow, at the Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. After having completed a PhD Thesis at the Université Libre de Bruxelles in September 2004, he became “Chercheur Qualifié” (Research Faculty Member – tenured position) at the National Foundation for Scientific Research (FNRS, Belgium) in 2005. In March 2010, he took over the lead of the Breast Cancer Translational Research Laboratory J-C Heuson. In October 2013, he was appointed “Maître de Recherche” (Senior Research Associate – tenured position) by the National Foundation for Scientific Research (FNRS, Belgium), and also one of the “Chefs de Clinique” (Heads of clinic) at the Medical Oncology Clinic of the Institut Jules Bordet. He is Elected Member of the Scientific Council of the International Agency for Research on Cancer (World Health Organisation 2012 – 2016) and Elected Fellow of the European Academy of Cancer Sciences (since 2010), which is hosted under the auspices of European CanCer Organization (ECCO). He is also Advisory Council Member of the Susan G. Komen for the Cure (since June 2010). Dr. Sotiriou is reviewer for several high impact peer-reviewed journals. He has been elected associated editor of the Annals of Oncology Journal (Breast tumors) (January 2014-December 2015). Internationally renowned researcher, author and co-author of over 160 peer-reviewed articles, Dr. Sotiriou is focusing his research on genomics in breast cancer.
Dimitrios H. Roukos, MD, PhD, is Professor of Surgery – Precision Cancer Medicine and Founding director of “Centre for Biosystems and Genome Network Medicine” in the Ioannina University, School of Medicine. Assessing the unmet needs of traditional linear single – gene research, he has shifted to intrapatient comprehensive coding and non-coding genomic and regulatory network heterogeneity in time and space towards the achievement of Precision Cancer Medicine. He has published > 240 PubMed papers, 32 on Precision Medicine and Oncology, and 44 on static and spatiotemporal genome analysis with NGS. These publications have received more than 8756 citations with h-index: 73 (Scopus). He is reviewer in many high impact journals including some with impact factor (IF) >30, evaluator in innovative research projects (EU, France, Belgium, Luxemburg, Poland), member in the editorial board of 25 international journals with IF, and Organizing Committee member in >20 International Conferences.
Aurelian Udristioiu, M.D,Primary Physician, EuSpLM,City Targu Jiu, Romania National Academy of Biochemical Chemistry (NACB) Member, Washington D.C, USA. Fellow PhD in Molecular Biology, Titu Maiorescu University, General Medicine Faculty, Bucharest, Romania. Man of Medical Year/2015 at the International Bibliographic Center, IBC, Cambridge, UK.
Branca M. Silva has completed her Ph.D in Pharmaceutical Sciences (Nutrition and Food Chemistry branch) from the Faculty of Pharmacy – University of Porto (Porto, Portugal) in 2005. Currently, she is an Associate Professor at the Faculty of Health Sciences – University of Beira Interior (Covilhã, Portugal). She is (co)author of about 100 scientific papers and book chapters, has more than 3650 citations and an h-index of 33. Her research interests are oriented to the Medicinal Phytochemistry, Food Chemistry and Nutrition areas. Currently, she is an Academic Editor of the Journal of Chemistry (Hindawi Publishing Corporation). She is also Editorial Board Member and reviewer of several international journals and co-editor of 2 books (Bentham Science Publishers).
Sergey Suchkov was born in the City of Astrakhan, Russia. In 1980, graduated from Astrakhan State Medical University with MD. In 1985, maintained his PhD at the I.M. Sechenov Moscow Medical Academy and Inst of Med Enzymology. In 2001, his Doctor Degree at the Nat Inst of Immunology in Russia. From 1989 through 1995, was a Head of the Lab of Clin Immunology, Helmholtz Eye Research Inst in Moscow. From 1995 through 2004 - a Head of the Dept for Immunology, Moscow Clin Res Inst (MONIKI). In 1993-1996, was a Secretary-in-Chief of the Edit Board, Biomedical Science, an IntJ published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov, MD, PhD, is: ● Professor in Medicine, Director, Center for Personalized Medicine, Sechenov University and Professor in Immunology, Dept of Clinical Immunology, A.I.Evdokimov Moscow State Medical and Dental University; ● Professor in Medicine, Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Russia ● Secretary General, United Cultural Convention (UCC), Cambridge, UK. DrSuchkov is a member of the:● New York Academy of Sciences, USAl; ● American Chemical Society (ACS), USA;● American Heart Association (AHA), USA;● European Association for Medical Education (AMEE), Dundee, UK;● EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU;● ARVO (American Association for Research in Vision and Ophthalmology);● ISER (International Society for Eye Research);● Personalized Medicine Coalition (PMC), Washington, DC, USA; DrSuchkov is a member of the Editorial Boards of EPMA J., American J. of Cardiovascular Research and “Personalized Medicine Universe”etc
Shahla Masood is a Persian born physician, who currently holds the positions of Professor and Chair of the Department of Pathology at University of Florida College ofrnMedicine – Jacksonville and Chief of Pathology and Laboratory Medicine at UF Health Jacksonville. In addition, Dr. Masood is the Medical Director of UF Health BreastrnCenter. An internationally recognized expert in breast cancer diagnosis and prognosis, Dr. Masood has fostered the concept of an integrated multidisciplinary approachrnin breast cancer care, research, and education. She is the founder and Editor-in-Chief of The Breast Journal, the founder and past president of the “International Societyrnof Breast Pathology,” the Director of the “Annual Multidisciplinary Symposium on Breast Disease”, and “The Breast Cancer Public Forum”. Dr. Masood is heavily involvedrnin the study of minimally invasive procedures such as fine needle aspiration biopsy and ductal lavage in providing diagnostic and prognostic information in high risk andrnbreast cancer patients. She defined the cytomorphology of high-risk proliferative breast disease in the early 1990s and has pioneered the concept of cytomorphology as arnbreast cancer predictor. Dr. Masood is the author of several textbooks, book chapters, and numerous publications. She is a frequent speaker at national and internationalrnsymposiums and consensus meetings. She is also a member of the board of trustees of several prestigious scientific societies and organizations at local, regional, nationalrnand international levels. Dr. Masood has received numerous awards and recognition for her scientific work, her contribution to advancing global breast health educationrnand her efforts to improve the quality of breast health care. She is the recipient of “The 2010 Breast Health Global Initiative Award,” “Courage to Teach Award” from NationalrnAccreditation Council for Graduate Medical Education, and Florida Times Union “Eve Award,” to name a few. She has been named as one of the Top Doctors in America,rnTop Doctors in Cancer and one of the 20 Top Most Influential Professors in Oncology at an international level. She was recently recognized at the 15 Year Anniversary ofrnRace for a Cure in Rome, Italy for her efforts in initiation of the Komen Italia, Race for the Cure.
Professor Osmar Antonio Centurión, is a cardiologist with expertise in Coronary Heart Diseases and Cardiac Arrhythmias, Hemodynamics and Electrophysiology and Arrhythmia Ablation. He is Professor of Medicine at the School of Medical Sciences from the Asuncion National University in Asunción, Paraguay. He received is PhD degree in Cardiology, at the Nagasaki University School of Medicine, Nagasaki, Japan in 1994. He is the Founding Member of Sociedad Latinoamericana de Cardiología Intervencionista (SOLACI). Author of more than 200 medical articles published in peer-reviewed American, European and Japanese journals in cardiology. His biography is published in "Who is Who in the World", "Who is Who in Science and Engineering", "Man of Achievement", "Who is who in Medicine and Healthcare". He is a Fellow of the American College of Cardiology, American Heart Association, and member of other 10 International Cardiovascular Societies. He is currently Chief of the Department of Cardiology, Hospital de Clinicas, Asunción, Paraguay. In addition, He is the Director of the Department of Health Science Investigation at the Metropolitan Hospital, Fernando de la Mora, Paraguay. He is currently Member of the Editorial Board of more than 50 international scientific journals. The following are just some of the cardiovascular international journals: Angiology, JAFIB, Journal of Atrial Fibrillation, The Open Cardiovascular Medicine Journal, Research in Cardiovascular Medicine, The Open Atherosclerosis and Thrombosis Journal, World Journal on Cardiovascular Disease, Hematology and Leukemia, Cardiology and Angiology: An International Journal, Journal of Pharmaceutical Technology & Drug Research, Journal of Bioequivalence & Bioavailability. He is Past-Editor-In-Chief of the Revista de la Sociedad Paraguaya de Cardiología, and current Editor-in-Chief of Mathews Journal of Cardiology, Blood, Heart and Circulation Journal, and Medplus Journal of Experimental Cardiology and Research.